Loading company…
PorTal Access develops vascular access devices for oncology patients.
PorTal Access, founded by Michael Tal and based in Miami, US, develops medical devices for vascular access in oncology. Its Flexi-Port™ SLF-TANL™ product is designed as a minimally invasive option for bedside and outpatient use. In May 2025, the company raised USD 7 million in Series A funding from MedVenture Health and Kidron Capital Assets.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in